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Clinical and cytogenetic characteristics of choroidal melanoma in
Vietnamese $sians
Tara A. McCannel,1 Melinda Y. Wu,2 Barry L. Burgess1
1Department of Ophthalmology and WKHJules Stein Eye Institute, University of California, Los Angeles, Los Angeles, CA; 2Washington
University School of Medicine, St. Louis, MO

Purpose: To report the clinical and cytogenetic characteristics of choroidal melanoma in Vietnamese Asians.
Methods: In three Vietnamese Asians with choroidal melanoma, transscleral fine needle aspiration biopsy (FNAB) was
performed immediately before Iodine-125 brachytherapy. Biopsy was examined for cytopathology, fluorescence in situ
hybridization (FISH) for the centromere of chromosome 3, and analyzed by 250K whole genome Mapping Array and
U133 plus 2.0 Expression Array.
Results: Three Vietnamese Asian men (50, 59, and 30 years of age) with clinical diagnosis of choroidal melanoma and
no evidence of metastasis had FNAB immediately before Iodine-125 brachytherapy. Cytopathology showed heavily
pigmented cells suggestive of or consistent with melanoma. Mapping Array and Expression Array revealed cytogenetic
aberrations and gene expression profiles characteristic of choroidal melanoma. One patient (Case 2) with chromosome 3
loss and chromosome 8q gain developed biopsy-proven liver metastasis three years after brachytherapy. One patient (Case
1) with chromosome 6p, 9q and 17q gain and a second patient (Case 3) with 6p, 8q and 9q gains and losses in 6q and 8p
have had no evidence of metastasis three years after brachytherapy.
Conclusions: In this series of Vietnamese Asians with heavily pigmented choroidal melanoma, the clinical characteristics,
cytogenetic aberrations and gene expression profiles were similar to characteristics in other ethnic/racial groups and the
cytogenetic aberration of chromosome 3 loss was associated with the development of liver metastasis.

Choroidal melanoma is the most common primary
intraocular malignancy in adults. Studies from various
countries have reported annual incidence rates between 5.3
and 10.9 cases per million [1]. A recent report found that the
annual incidence of choroidal melanoma in the United States
per million was 6.02 in non-Hispanic whites, 1.67 in
Hispanics, 0.38 in Asians, 0 in Native Americans, and 0.31 in
blacks [2].
Asian refers to persons with origin in any of the original
peoples of Asia and is further characterized by culture and
ancestry to a specific country or region [3]. In this context,
choroidal melanoma has been reported in Japanese Asians,
Chinese Asians, Thai Asians, and others of Asian origin
[4-7]. We are not aware, however, of a prior report of
choroidal melanoma in Vietnamese Asians.
We report a series of three Vietnamese Asians with
choroidal melanoma. The clinical presentation and clinical
course of disease, the cytogenetic aberrations and the gene
expression profiles revealed by high-density single nucleotide
polymorphism (SNP) mapping array and expression array are
presented.
METHODS
All studies were performed in accordance with the
Declaration of Helsinki and the United States Health

Insurance Portability and Accountability Act (HIPAA) of
1996. All participants gave informed consent and all studies
were approved by the Office of Human Research Protection
(Institutional Review Board) of the University of California,
Los Angeles.
Patients were self-declared Vietnamese Asians on the
basis of Vietnamese ancestry and identification with the social
and cultural characteristics of Vietnam [3].
Clinical diagnosis of choroidal melanoma was
established by comprehensive ophthalmology examination,
fundus photography, fluorescein angiography, and
ultrasonography.
Transscleral fine needle aspiration biopsy (FNAB),
cytopathology, fluorescence in situ hybridization (FISH) for
the centromere of chromosome 3, and analysis by 250K
Mapping Array (Affymetrix, Santa Clara, CA) for
chromosome copy number and U133 plus 2.0 Array
(Affymetrix) for gene expression were performed as
described previously [8-11]. Briefly, probe preparation,
hybridization, and reading were performed by the UCLA
DNA Microarray Core (Los Angeles, CA), according to the
standard 96-well protocol published by Affymetrix. Copy
number variation was computed using CNAT v4.0.1 software
from Affymetrix.

Correspondence to: Tara A. McCannel, M.D., Ph.D., 100 Stein Plaza,
UCLA, Los Angeles, CA, 90095; Phone: (310) 206-7484; FAX:
(310) 794-4904; email: TMcCannel@jsei.ucla.edu

RESULTS
Case 1: A previously healthy 50-year-old Vietnamese man
presented with a three month history of photopsia and “black
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Figure 1. Color fundus photograph of
the left eye in Case 1 at initial
presentation demonstrates a superonasal
pigmented choroidal melanoma.

Figure 2. Chromosomal aberrations determined by high-density genome single nucleotide polymorphism mapping (SNP) array in fine needle
aspiration biopsy specimens. Summary of accumulated chromosomal gain and loss data from GeneChip 250k NspI mapping arrays for biopsies
of the three patients is demonstrated. Red boxes denote whole or partial loss; green boxes denote a whole or partial gain; green boxes labeled
2× denote a two-copy gain.

vision” in the left eye. Visual acuity was 20/20 in the right eye
and Count Fingers at 3 feet in the left eye. The left eye had an
inferior and central field defect and left exotropia was present.
The right eye was unremarkable. Funduscopy of the left eye
revealed a heavily pigmented choroidal tumor in the
superonasal periphery with extensive subretinal hemorrhage
in the superior fundus and upper part of the macula (Figure
1). Ultrasonography showed a mushroom-shaped choroidal
tumor with low to medium reflectivity, height of 8.10 mm and
basal dimensions of 9.99 mm by 11.20 mm.

placement. Cytopathology showed pigmented cells
suspicious for melanoma and fluorescence in situ
hybridization (FISH) for chromosome 3 revealed normal
disomy pattern. Whole genome Mapping Array demonstrated
chromosome gains in 6p, 9q and 17q (Figure 2).

With clinical diagnosis of choroidal melanoma, left eye,
and no evidence of metastasis, the patient was treated with
Iodine-125 brachytherapy and transscleral fine needle
aspiration biopsy (FNAB) immediately before plaque

Case 2: A previously healthy 59-year-old Vietnamese man
presented with sudden onset of decreased vision in the left eye.
Best corrected visual acuity was 20/20 in the right eye and
Hand Motions at 2 feet in the left eye. The right eye was

The patient has been followed for three and a half years
after brachytherapy with liver function testing and imaging by
positron emission tomography-computed tomography (PETCT) yearly. There has been no evidence of melanoma
metastasis.
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Figure 3. Color fundus photograph of
the left eye in Case 2, one year after
Iodine-125 plaque brachytherapy,
demonstrates a regressed pigmented
choroidal melanoma.

detected on LASIK follow-up examination. Visual acuity was
20/20 in each eye. The right eye had no significant
abnormality. Funduscopy of the left eye showed a pigmented
choroidal tumor in the inferotemporal equatorial region with
overlying subretinal fluid (Figure 4). Fluorescein angiography
demonstrated intratumor vascularization and ultrasonography
revealed a dome-shaped tumor with low internal reflectivity,
height of 3.92 mm and basal measurements of 10.70 mm by
11.07 mm.

unremarkable. Funduscopy of the left eye revealed a dense
vitreous hemorrhage that obscured details of a choroidal
tumor in the superotemporal equatorial region.
Ultrasonography showed a dome-shaped choroidal mass with
medium to high reflectivity, height of 6.29 mm and basal
measurements of 9.36 mm by 11.77 mm.
Following clinical diagnosis of choroidal melanoma, left
eye, and systemic medical evaluation that showed no evidence
of metastasis, the patient was treated with Iodine-125
brachytherapy. FNAB immediately before plaque application
showed densely pigmented cells suspicious for melanoma and
consistent with necrotizing melanocytoma. FISH for
chromosome 3 revealed normal disomy pattern, but Mapping
Array documented chromosome 3 loss and 8q gain (Figure 2).
One year after brachytherapy, the vitreous hemorrhage
had cleared and funduscopy revealed a melanotic choroidal
tumor that measured 5.57 mm in height by ultrasonography
(Figure 3). Liver function testing and PET-CT imaging was
performed yearly. Three years after brachytherapy, imaging
studies demonstrated liver lesions that were biopsy-proven to
be melanoma metastases.

Choroidal melanoma was diagnosed and systemic
medical evaluation showed no evidence of metastasis. The left
eye was treated with Iodine-125 brachytherapy. FNAB
immediately before plaque placement showed pigmented
cells diagnostic of choroidal melanoma and FISH for
chromosome 3 had normal disomy pattern. Mapping Array
demonstrated chromosomal aberrations consisting of gains in
6p, 8q and 9q as well as losses in 6q and 8p.
The patient has been followed for three and a half years
after brachytherapy with liver function testing and imaging by
PET-CT yearly. There has been no evidence of melanoma
metastasis.
Molecular analysis: The results of high density, whole
genome 250K Mapping Array for the three cases are presented
in Figure 2. Loss of one copy of chromosome 3 (monosomy

Case 3: A 30-year-old Vietnamese man with a history of laserassisted in situ keratomileusis (LASIK) two years previously
was referred because of pigmented lesion in the left eye
233
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Figure 4. Color fundus photograph of
the left eye in Case 3 at initial
presentation
demonstrates
an
inferotemporal choroidal melanoma.

3) was demonstrated in one patient (Case 2). FISH in this
patient showed normal disomy signal pattern, but the patient
progressed to biopsy proven liver metastasis three years after
brachytherapy.
The two other patients (Case 1 and Case 3) had
chromosome 6p gain in the absence of chromosome 3 loss, as
well as 9q and 17q gain in Case 1 and gains in 8q and 9q and
losses in 6q and 8p in Case 3. These patients have been
followed for three years after brachytherapy without evidence
of melanoma metastasis.
The results of U133 plus 2.0 Array for gene expression
for Case 2 and 3 with respect to the 25 most highly upregulated
genes and 20 most down-regulated genes identified in a
previous study of monosomy 3 choroidal melanomas relative
to chromosome 6p [11] choroidal melanomas are shown in
Figure 5. Insufficient RNA was available to perform this
analysis in Case 1.

on ultrasonography was comparable to presentation of
choroidal melanoma in other ethnic and racial groups. Even
the heavy pigmentation in the tumor of Vietnamese men was
equivalent to the heavy pigmentation of choroidal melanoma
pigmentation reported in Asians from Japan, China, and
Thailand [4-6].
Of particular significance in this report of Vietnamese
adults were the melanoma cytogenetic abnormalities and gene
expression profiles. Cytogenetic aberrations in the choroidal
melanomas included chromosome 3 loss by Mapping Array
in Case 2 and chromosome 6p gain with normal chromosome
3 disomy in Case 1 and Case 3. Surprisingly, FISH for the
centromere of chromosome 3 in Case 2 showed a normal
pattern of disomy. This may represent tumor heterogeneity or
cells from normal stroma or adjacent normal tissue in the
sample studied by FISH. Whole gene Mapping Array, which
is a more reliable test9, documented chromosome 3 loss in
Case 2.
Gene expression in choroidal melanoma of these three
Vietnamese men showed profiles of upregulation and downregulation for the 25 most upregulated and the 20 most downregulated genes in a comparative gene list. The comparative
gene list was derived from a comparison of gene expression
in 59 choroidal melanomas comparing melanomas with
chromosome 3 loss versus melanomas with 6p gain [11].

DISCUSSION
In this series of three Vietnamese men, clinical presentation
of choroidal melanoma with photopsia, vision loss or
discovery on ophthalmologic examination, and appearance of
a dome-shaped or mushroom-shaped choroidal mass with
subretinal fluid or hemorrhage, and low to medium reflectivity
234
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Figure 5. Expression Array Data Comparison of Two Cases. Normalized GeneChip Human U133 Plus 2.0 expression array data comparing
Case 2 and Case 3 for mRNA expression in the 25 most highly upregulated genes and 20 most down-regulated genes identified in a previous
study of monosomy 3 choroidal melanomas relative to chromosome 6p gain choroidal melanomas [11]. Insufficient RNA was available for
analysis of Case 1.

Significantly, the Vietnamese choroidal melanoma patient
with chromosome 3 loss (Case 2) had a gene expression
profile similar to the larger comparative group of choroidal
melanomas with chromosome 3 loss. The Vietnamese patient
with choroidal melanoma with chromosome 6p gain and the
absence of chromosome 3 loss (Case 1) presented a profile of
gene expression similar to the larger comparative group of
choroidal melanomas with 6p gain.

In Case 2, FISH probing for the centromeric region of
chromosome 3 yielded disomy 3, which was discrepant with
Mapping array data which showed a loss of one copy of
chromosome 3. The reasons for this discrepancy may be that
tumor heterogeneity resulted from different areas of the tumor
biopsied [12-14]. In addition sampling error in the biopsy may
have resulted in an analysis of a significant number of
macrophages or lymphocytes, rather than actual melanoma
cells [15].

Overall, clinical presentation of choroidal melanoma in
Vietnamese patients closely paralleled the symptoms and
signs of choroidal melanoma in other ethnic/racial groups and
documented the dense melanin pigmentation characteristic of
choroidal melanoma in Asians of Japanese, Chinese, and Thai
origin [4-6].

Similarities between this small series of three Vietnamese
Asians with choroidal melanoma and the larger experience of
primarily white patients with choroidal melanoma suggests a
similar underlying disease process and infers applicability to
the Vietnamese of prognostic information and, ultimately,
therapeutic measures derived from larger cohorts of white
patients with choroidal melanoma.

Cytogenetic presentation in Vietnamese patients showed
fundamental features of chromosome 3 loss (Case 2) and
chromosome 6p gain (Cases 1 and 3) comparable to the
cytogenetic characteristics of primarily Caucasian patients.
Moreover, the gene expression profile of the patient with
chromosome 3 loss (Case 2) and chromosome 6p gain (Case
1) were similar to the gene profiles for the most upregulated
and most down-regulated genes in a primarily Caucasian
group [11].

Strengths of this report relate to the (1) self-determined
identification of Vietnamese Asians on the basis of ancestry
and culture, (2) characterization of clinical presentation,
diagnosis, treatment and clinical course in Vietnamese men
with choroidal melanoma, and (3) use of identical Mapping
Array and Expression Array to characterize cytogenetic
aberrations and gene expression profiles in Vietnamese men
and a larger cohort of white patients with choroidal melanoma.
Weaknesses include the (1) small series of three Vietnamese
men with choroidal melanoma and (2) rather short posttreatment follow-up of three years.

Occurrence of biopsy-confirmed melanoma metastasis in
the liver of the Vietnamese patient with chromosome 3 loss
(Case 2) three years after brachytherapy and no evidence of
metastasis in the Vietnamese patients with chromosome 6p
gain (Cases 1 and 3) followed for an equal period after
brachytherapy was consistent with the high risk of metastasis
associated with chromosome 3 loss.

Although uveal melanoma is rare in Asians, these data
indicate that when it does occur, the underlying chromosome
and RNA changes are the same as those that occur in
Caucasians. In Vietnamese Asians with heavily pigmented
235
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choroidal melanoma, clinical presentation, cytogenetic
characteristics and gene expression profiles were similar to
larger series of primarily white patients with choroidal
melanoma. Chromosome 3 loss was associated with a poor
prognosis and development of liver metastasis.
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